Effects of Locoregional Treatment and "Downstaging" on Long-Term Post-Liver Transplant Outcomes for Patients with Hepatocellular Carcinoma

被引:0
|
作者
Dzebisashvili, N. [1 ]
Stark, C. [1 ]
Mezochow, G. [1 ]
Harper, A. [2 ]
Edwards, E. [2 ]
Axelrod, D. [1 ]
Freeman, R. [1 ]
机构
[1] Dartmouth Hitchcock Med Ctr, Dept Surg, Lebanon, NH 03766 USA
[2] UNOS, Richmond, VA USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:45 / 45
页数:1
相关论文
共 50 条
  • [1] Effects of Locoregional Treatment and "Downstaging" on Long-Term Post-Liver Transplant Outcomes for Patients with Hepatocellular Carcinoma.
    Dzebisashvili, Nino
    Stark, Christina
    Mezochow, Gabrielle
    Harper, Ann
    Edwards, Erick
    Axelrod, David
    Freeman, Richard
    [J]. LIVER TRANSPLANTATION, 2013, 19 : S117 - S117
  • [2] Worse Long-Term Post-Transplant Outcomes for Liver Recipients with Hepatocellular Carcinoma
    Luo, Xun
    Massie, Allan
    Choudhury, Rashikh
    Segev, Dorry
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 82 - 83
  • [3] Effects of Hepatitis C Virus on Longterm Post-Liver Transplant Outcomes for Patients with Hepatocellular Carcinoma.
    Dzebisashvili, Nino
    Stark, Christina
    Mezochow, Gabrielle
    Harper, Ann
    Edwards, Erick
    Axelrod, David
    Freeman, Richard
    [J]. LIVER TRANSPLANTATION, 2013, 19 : S119 - S119
  • [4] THE LASTING IMPACT OF SOCIOECONOMIC FACTORS ON POST-LIVER TRANSPLANT OUTCOMES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Huang, Dora C.
    Yu, Rosa
    Alqahtani, Saleh A.
    Tamim, Hani
    Saberi, Behnam
    Bonder, Alan
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1141 - S1142
  • [5] THE RISK OF RECURRENT HEPATOCELLULAR CARCINOMA IN POST-LIVER TRANSPLANT PATIENTS RECEIVING CAPECITABINE TREATMENT
    Alsager, Mohammed
    Chaitanya, Vishwa
    Gandhi, Radhika
    Puka, Klajdi
    Tang, Ephraim
    Teriaky, Anouar
    Qumosani, Karim M.
    Skaro, Anton I.
    Parfitt, Jeremy
    Brahmania, Mayur
    [J]. HEPATOLOGY, 2020, 72 : 710A - 711A
  • [6] Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging
    Affonso, Breno Boueri
    Galastri, Francisco Leonardo
    da Motta Leal Filho, Joaquim Mauricio
    Nasser, Felipe
    Falsarella, Priscila Mina
    Cavalcante, Rafael Noronha
    de Almeida, Marcio Dias
    Goncalves Felga, Guilherme Eduardo
    Moreira Valle, Leonardo Guedes
    Wolosker, Nelson
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (37) : 5687 - 5701
  • [7] Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging
    Breno Boueri Affonso
    Francisco Leonardo Galastri
    Joaquim Mauricio da Motta Leal Filho
    Felipe Nasser
    Priscila Mina Falsarella
    Rafael Noronha Cavalcante
    Marcio Dias de Almeida
    Guilherme Eduardo Gon?alves Felga
    Leonardo Guedes Moreira Valle
    Nelson Wolosker
    [J]. World Journal of Gastroenterology, 2019, (37) : 5687 - 5701
  • [8] Long-Term Outcomes of Calcineurin Inhibitor Withdrawal for Post-Liver Transplant Renal Dysfunction
    Mackay, A. J.
    Angus, P. W.
    Gow, P. J.
    [J]. TRANSPLANTATION PROCEEDINGS, 2011, 43 (10) : 3802 - 3806
  • [9] Locoregional Therapy and Long-Term Post-Transplant Outcomes for HCC Liver Transplant Recipients.
    Ishaque, T.
    Weeks, S. R.
    Kolarich, A.
    Ruck, J.
    Garonzik-Wang, J.
    Segev, D.
    Massie, A.
    King, B.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 820 - 820
  • [10] The Impact of Treatment of Hepatocellular Carcinoma With Immune Checkpoint Inhibitors on Pre- and Post-liver Transplant Outcomes
    Dave, Shravan
    Yang, Kun
    Schnickel, Gabriel T.
    Kono, Yuko
    Delebecque, Fanny
    Arellano, Deyna
    Liu, Amy
    Zhang, Xinlian
    Tu, Xin M.
    Ajmera, Veeral
    [J]. TRANSPLANTATION, 2022, 106 (06) : E308 - E309